Group items tagged

AngioDynamics has received approval from the US Food and Drug Administration (FDA) for an investigational device exemption (IDE) application of its NanoKnife System in the treatment of stage III pancreatic cancer.

UK department store chain Debenhams has secured £200m ($261m) in funds from its existing lenders.

Smith & Nephew has entered an agreement to acquire medical device company Leaf Healthcare, including its patient mobility monitoring device Leaf Patient Monitoring System.

Avanos Medical has secured US Food and Drug Administration (FDA) 501(k) clearance for its postoperative pain management device ON-Q Bolus.

Business consultancy Frost & Sullivan has made a series of predictions for the future of the patient monitoring device market, following its recently published analysis of investments and trends in the industry.

The US Food and Drug Administration (FDA) has rejected Helius Medical Technologies' premarket submission for the Portable Neuromodulation Stimulator (PoNS) device due to a lack of data.

French supermarket chain Carrefour Supermarkets has announced it will open more than 200 Gome outlets in China.

A six-month trial at Queen Mary's Hospital in Sidcup, UK has demonstrated the successful implementation of eTriage, an electronic triage system designed to reduce hospital waiting times by accelerating initial personal assessment.

Scientists have developed a new technique to measure brain function in milliseconds using magnetic resonance imaging (MRI).

Ireland-headquartered fast fashion retailer Primark has today opened its largest store in the world in Birmingham, UK.

When different franchisors start accepting new franchise deals in various locations, they initially make a loss with the aim of making a long-term profit from the sales return of the connected franchise.

Synchron has launched the first clinical trial of its neural interface technology Stentrode.

A new study in the US demonstrated that an artificial intelligence (AI)-based software could aid in the diagnosis of post-traumatic stress disorder (PTSD) in veterans by examining their voices.

Johnson & Johnson (J&J) subsidiary Ethicon has been ordered to pay $120m in damages by a Philadelphia court after it ruled that its negligently designed pelvic mesh implant caused a Pennsylvania woman to suffer from incontinence and chronic pain, Law360 has reported.

Analytics firm Elsevier has teamed up with non-profit phactMI to develop a new solution for providing scientifically accurate information to healthcare professionals.

Researchers at Harvard University in the US have designed a probe that looks, acts and feels like a real neuron so that the brain does not identify it as a foreign object and try to attack it.

A team at IBM Research Australia is developing a blood test to detect early stage Alzheimer's disease. Led by researcher Ben Goudey, the team used artificial intelligence (AI) technology to identify a set of proteins in blood that could predict amyloid-beta concentration in spinal fluid.

France-based personal care and beauty store chain Sephora has announced its plans to open 35 new locations across the US this year.

US drugstore chain Rite Aid has announced it is planning to reduce managerial layers and consolidate roles across the organisation as part of its organisational restructuring, which could result in the loss of approximately 400 full-time jobs.

Biotronik has secured approval from the US Food and Drug Administration (FDA) for the use of its Acticor and Rivacor cardiac rhythm management (CRM) devices to treat heart arrhythmias.